CFDE Data Portal | Search UBBP4

	Label	Description
	UBBP4 associations Collection (Entity type)	Associations for UBBP4_associations
	UBBP4 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	UBBP4 Gene (Entity type)	ENSG00000290919 - ubiquitin B pseudogene 4
	GSE153871 cytarabine U2OS 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE73573 KDM1B knockdown 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE205714 GSE229013 adenosine 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE173577 MEK inhibition DK1 [Tursiops] 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE236502 paclitaxel 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE238018 MXRA8 knockout MDA-MB-231 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE103567 EZH2 inhibition 5 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS

UBBP4 associations

Associations for UBBP4_associations

UBBP4 associations.tsv

A file from IDG as part of the Harmonizome project

UBBP4

ENSG00000290919 - ubiquitin B pseudogene 4

GSE153871 cytarabine U2OS 0 v 3 human dn

A Gene Set from LINCS

GSE73573 KDM1B knockdown 1 v 0 human dn

A Gene Set from LINCS

GSE205714 GSE229013 adenosine 3 v 2 human up

A Gene Set from LINCS

GSE173577 MEK inhibition DK1 [Tursiops] 2 v 1 human dn

A Gene Set from LINCS

GSE236502 paclitaxel 2 v 3 human up

A Gene Set from LINCS

GSE238018 MXRA8 knockout MDA-MB-231 3 v 2 human dn

A Gene Set from LINCS

GSE103567 EZH2 inhibition 5 v 2 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.